Efficacy and safety of mesenchymal stem cell injections for patients with osteoarthritis: a meta-analysis and review of RCTs
- PMID: 33507375
- DOI: 10.1007/s00402-020-03703-0
Efficacy and safety of mesenchymal stem cell injections for patients with osteoarthritis: a meta-analysis and review of RCTs
Abstract
Introduction: Osteoarthritis (OA), which has a high incidence in the elderly, brings a huge economic burden to society. MSCs (Mesenchymal Stem Cells) have shown great multidirectional differentiation potential which are expected to treat OA, and numerous clinical trials have been conducted. However, the efficacy and safety of the MSCs still need to be further integrated and analyzed.
Materials and methods: We searched several databases (PubMed, EMBASE, Scopus, Web of Science, Cochrane Library, Ovid, and ScienceDirect) for assessing eligible trials that randomized controlled trials, hyaluronic acid as control, and MSCs injection to treat OA. Vitro studies and animal studies were excluded. Search terms were: "cartilage," "clinical trial," "mesenchymal," "stromal" and "stem cell", "osteoarthritis". The preliminary guidelines and study protocol were published online at PROSPERO.
Results: Many assessment scales could not be improved significantly after 6 months. However, most of the scales were significantly improved after 12 months, indicating that compared with hyaluronic acid, stem cells could relieve OA symptoms significantly. No serious adverse effect was found.
Conclusion: There are significant therapeutic effects on joint function, symptoms, and no permanent adverse effect has been found after stem cell treatment. It is promising to apply intro-articular injection of stem cells for OA to clinical application. More researches are needed to supplement present deficiencies.
Keywords: Adverse effects; Mesenchymal stem cells; Osteoarthritis; Therapy.
References
-
- Bijlsma JWJ, Berenbaum F, Lafeber FPJG (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377(9783):2115–2126. https://doi.org/10.1016/S0140-6736(11)60243-2 - DOI - PubMed
-
- Lin J, Fransen M, Kang X, Li H, Ke Y, Wang Z, Zhang Y, Su S (2010) Marked disability and high use of nonsteroidal antiinflammatory drugs associated with knee osteoarthritis in rural China: a cross-sectional population-based survey. Arthr Res Ther 12(6):R225. https://doi.org/10.1186/ar3212 - DOI
-
- Strotman PK, Novicoff WM, Nelson SJ, Browne JA (2019) Increasing public interest in stem cell injections for osteoarthritis of the hip and knee: a google trends analysis. J Arthroplast 34(6):1053–1057. https://doi.org/10.1016/j.arth.2019.03.002 - DOI
-
- Reisbig NA, Pinnell E, Scheuerman L, Hussein H, Bertone AL (2019) Synovium extra cellular matrices seeded with transduced mesenchymal stem cells stimulate chondrocyte maturation in vitro and cartilage healing in clinically-induced rat-knee lesions in vivo. PLoS ONE 14(3):e0212664. https://doi.org/10.1371/journal.pone.0212664 - DOI - PubMed - PMC
-
- Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076–1084 - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
